Advertisement DRJ Group expands skin care products portfolio - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

DRJ Group expands skin care products portfolio

DRJ Group, the makers of Stopain topical analgesics has announced a recent expansion of the company's product line with a patented cream formula with new, easy-to-read packaging and increased availability for the Stopain family of products.

The company recently unveiled a cream which is formulated to provide lasting pain relief. Stopain Cream incorporates Invisicare, an extended-release polymer technology that works on contact, rapidly and continuously releasing active ingredients on the skin. This allows it to remain effective longer, without the need to constantly reapply.

Bob Miller, president and CEO of DRJ Group, said: “Our business philosophy is to focus on customer feedback when it comes to managing pain. We are extremely excited to offer these new enhancements to Stopain products, packaging and distribution. Our mission is to help people manage their pain so they can lead richer, more active lives.”